Groove Botanicals Current Ratio
Current Ratio of Groove Botanicals (GRVE) as of Aug 16, 2026.
Get this data via API
Financial Data API
Current Ratio
0.00
YoY
39.99%
Last updated:
Current Ratio of Groove Botanicals is 2026 0.00 . Current Ratio of Groove Botanicals was 2025 0.00 . It decreases by 39.99% higher compared to the previous year.
Access this data via the Eulerpool API
Groove Botanicals Stock analysis
What does Groove Botanicals do? Groove Botanicals Inc. is an American company that specializes in the sale of natural and organic products. It was founded in 2005 by a group of friends who were interested in healthy food, medicinal herbs, and sustainable production. The company aims to provide a healthy alternative to conventional and often unhealthy products, while also contributing to environmental protection and sustainability. They offer a range of products in the wellness, body care, beauty, and health sectors, including natural supplements, cosmetics, essential oils, herbal teas, and more. They also specialize in the production and distribution of CBD products, using high-quality ingredients and sustainable production methods. In addition to their business operations, Groove Botanicals is committed to environmental protection and sustainability. Groove Botanicals is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Groove Botanicals stock
On Eulerpool you can find the complete historical development of Current Ratio Groove Botanicals since 2006 – with annual values, charts, and detailed analysis.
The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.
Current Ratio = Current Assets / Current Liabilities
A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Groove Botanicals with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
Leverage — Groove Botanicals
All Key Metrics — Groove Botanicals
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth